ALT 0 3 0 3 B-clinical_variable
or 4 6 4 6 O
BUN 7 10 7 10 B-clinical_variable
> 11 12 11 12 O
2.0 12 15 12 15 B-lower_bound
ULN 16 19 16 19 I-lower_bound
or 20 22 20 22 O
estimated 23 32 23 32 B-clinical_variable
creatinine 33 43 33 43 I-clinical_variable
> 44 45 44 45 O
1.5 45 48 45 48 B-lower_bound
X 49 50 49 50 I-lower_bound
ULN 51 54 51 54 I-lower_bound
for 55 58 55 58 O
age 59 62 59 62 B-age
or 63 65 63 65 O
any 66 69 66 69 O
other 70 75 70 75 O
laboratory 76 86 76 86 O
abnormality 87 98 87 98 O
considered 99 109 99 109 O
by 110 112 110 112 O
the 113 116 113 116 O
Investigator 117 129 117 129 O
to 130 132 130 132 O
be 133 135 133 135 O
clinically 136 146 136 146 O
significant 147 158 147 158 O
within 159 165 159 165 O
14 166 168 166 168 B-upper_bound
days 169 173 169 173 I-upper_bound
before 174 180 174 180 O
Screening 181 190 181 190 O

Active 0 6 191 197 O
malignancy 7 17 198 208 B-cancer
of 18 20 209 211 O
any 21 24 212 215 O
type 25 29 216 220 O
, 29 30 220 221 O
or 31 33 222 224 O
history 34 41 225 232 O
of 42 44 233 235 O
a 45 46 236 237 O
malignancy 47 57 238 248 O

Any 0 3 249 252 O
disorder 4 12 253 261 B-chronic_disease
requiring 13 22 262 271 O
chronic 23 30 272 279 O
( 31 32 280 281 O
every 32 37 281 286 O
day 38 41 287 290 O
) 41 42 290 291 O
use 43 46 292 295 O
of 47 49 296 298 O
warfarin 50 58 299 307 B-treatment
, 58 59 307 308 O
carbamazepine 60 73 309 322 B-treatment
, 73 74 322 323 O
or 75 77 324 326 O
phenytoin 78 87 327 336 B-treatment
, 87 88 336 337 O
methotrexate 89 101 338 350 B-treatment
, 101 102 350 351 O
atazanavir 103 113 352 362 B-treatment
or 114 116 363 365 O
nelfinavir 117 127 366 376 B-treatment
, 127 128 376 377 O
clopidogrel 129 140 378 389 B-treatment
, 140 141 389 390 O
and 142 145 391 394 O
potent 146 152 395 401 B-treatment
inhibitors 153 163 402 412 I-treatment
and 164 167 413 416 O
inducers 168 176 417 425 O
of 177 179 426 428 O
CYP2C19 180 187 429 436 B-treatment

Body 0 4 437 441 B-clinical_variable
weight 5 11 442 448 I-clinical_variable
> 12 13 449 450 O
5th 14 17 451 454 B-lower_bound
percentile 18 28 455 465 I-lower_bound
for 29 32 466 469 O
age 33 36 470 473 B-age

Chronic 0 7 474 481 O
( 8 9 482 483 O
daily 9 14 483 488 O
) 14 15 488 489 O
use 16 19 490 493 O
of 20 22 494 496 O
glucocorticoids 23 38 497 512 B-treatment

Expected 0 8 513 521 O
survival 9 17 522 530 O
for 18 21 531 534 O
at 22 24 535 537 O
least 25 30 538 543 O
30 31 33 544 546 B-lower_bound
days 34 38 547 551 I-lower_bound

Female 0 6 552 558 O
subjects 7 15 559 567 I-gender
of 16 18 568 570 O
non 19 22 571 574 O
- 22 23 574 575 O
childbearing 23 35 575 587 O
potential 36 45 588 597 O
must 46 50 598 602 O
be 51 53 603 605 O
premenarchal 54 66 606 618 O
, 66 67 618 619 O
have 68 72 620 624 O
undergone 73 82 625 634 O
hysterectomy 83 95 635 647 B-treatment
with 96 100 648 652 I-treatment
bilateral 101 110 653 662 I-treatment
oophorectomy 111 123 663 675 I-treatment
, 123 124 675 676 O
have 125 129 677 681 O
medically 130 139 682 691 O
confirmed 140 149 692 701 O
ovarian 150 157 702 709 B-chronic_disease
failure 158 165 710 717 I-chronic_disease
, 165 166 717 718 O
or 167 169 719 721 O
achieved 170 178 722 730 O
post 179 183 731 735 O
- 183 184 735 736 O
menopausal 184 194 736 746 O
status 195 201 747 753 O

Fertile 0 7 754 761 O
male 8 12 762 766 B-gender
and 13 16 767 770 I-gender
female 17 23 771 777 I-gender
subjects 24 32 778 786 I-gender
of 33 35 787 789 O
childbearing 36 48 790 802 O
potential 49 58 803 812 O
at 59 61 813 815 O
risk 62 66 816 820 O
for 67 70 821 824 O
pregnancy 71 80 825 834 B-pregnancy
must 81 85 835 839 O
agree 86 91 840 845 B-contraception_consent
to 92 94 846 848 I-contraception_consent
use 95 98 849 852 I-contraception_consent
a 99 100 853 854 I-contraception_consent
highly 101 107 855 861 I-contraception_consent
effective 108 117 862 871 I-contraception_consent
method 118 124 872 878 I-contraception_consent
of 125 127 879 881 I-contraception_consent
contraception 128 141 882 895 I-contraception_consent
throughout 142 152 896 906 O
the 153 156 907 910 O
study 157 162 911 916 O
and 163 166 917 920 O
for 167 170 921 924 O
at 171 173 925 927 O
least 174 179 928 933 O
28 180 182 934 936 B-lower_bound
days 183 187 937 941 I-lower_bound
after 188 193 942 947 I-lower_bound
the 194 197 948 951 O
last 198 202 952 956 B-treatment
dose 203 207 957 961 I-treatment
of 208 210 962 964 I-treatment
assigned 211 219 965 973 I-treatment
treatment 220 229 974 983 I-treatment

History 0 7 984 991 O
of 8 10 992 994 O
sensitivity 11 22 995 1006 O
to 23 25 1007 1009 O
heparin 26 33 1010 1017 B-treatment
or 34 36 1018 1020 O
heparin 37 44 1021 1028 O
induced 45 52 1029 1036 O
thrombocytopenia 53 69 1037 1053 B-chronic_disease

History 0 7 1054 1061 O
of 8 10 1062 1064 O
treatment 11 20 1065 1074 B-treatment
with 21 25 1075 1079 I-treatment
any 26 29 1080 1083 I-treatment
PPI 30 33 1084 1087 I-treatment
within 34 40 1088 1094 O
2 41 42 1095 1096 B-upper_bound
days 43 47 1097 1101 I-upper_bound
( 48 49 1102 1103 I-upper_bound
48 49 51 1103 1105 I-upper_bound
hours 52 57 1106 1111 I-upper_bound
) 57 58 1111 1112 I-upper_bound
before 59 65 1113 1119 I-upper_bound
investigational 66 81 1120 1135 B-treatment
product 82 89 1136 1143 I-treatment
dosing 90 96 1144 1150 O
on 97 99 1151 1153 O
Day 100 103 1154 1157 O
1 104 105 1158 1159 O

In 0 2 1160 1162 O
the 3 6 1163 1166 O
Investigator 7 19 1167 1179 O
's 19 21 1179 1181 O
opinion 22 29 1182 1189 O
, 29 30 1189 1190 O
a 31 32 1191 1192 O
chronic 33 40 1193 1200 O
condition 41 50 1201 1210 O
( 51 52 1211 1212 O
eg 52 54 1212 1214 O
, 54 55 1214 1215 O
diabetes 56 64 1216 1224 B-chronic_disease
, 64 65 1224 1225 O
epilepsy 66 74 1226 1234 B-chronic_disease
) 74 75 1234 1235 O
, 75 76 1235 1236 O
which 77 82 1237 1242 O
is 83 85 1243 1245 O
either 86 92 1246 1252 O
not 93 96 1253 1256 O
stable 97 103 1257 1263 O
or 104 106 1264 1266 O
well 107 111 1267 1271 O
controlled 112 122 1272 1282 O
and 123 126 1283 1286 O
may 127 130 1287 1290 O
interfere 131 140 1291 1300 O
with 141 145 1301 1305 O
the 146 149 1306 1309 O
conduct 150 157 1310 1317 O
of 158 160 1318 1320 O
the 161 164 1321 1324 O
study 165 170 1325 1330 O

Known 0 5 1331 1336 O
history 6 13 1337 1344 O
of 14 16 1345 1347 O
HIV 17 20 1348 1351 B-chronic_disease
or 21 23 1352 1354 O
clinical 24 32 1355 1363 O
manifestations 33 47 1364 1378 O
of 48 50 1379 1381 O
AIDS 51 55 1382 1386 B-chronic_disease

Known 0 5 1387 1392 O
hypersensitivity 6 22 1393 1409 O
to 23 25 1410 1412 O
PPIs 26 30 1413 1417 B-allergy_name
or 31 33 1418 1420 O
to 34 36 1421 1423 O
any 37 40 1424 1427 O
substituted 41 52 1428 1439 O
benzimidazole 53 66 1440 1453 B-treatment
or 67 69 1454 1456 O
to 70 72 1457 1459 O
any 73 76 1460 1463 O
of 77 79 1464 1466 O
the 80 83 1467 1470 O
excipients 84 94 1471 1481 O

Other 0 5 1482 1487 O
severe 6 12 1488 1494 O
acute 13 18 1495 1500 O
or 19 21 1501 1503 O
chronic 22 29 1504 1511 O
medical 30 37 1512 1519 O
or 38 40 1520 1522 O
psychiatric 41 52 1523 1534 O
condition 53 62 1535 1544 O
or 63 65 1545 1547 O
laboratory 66 76 1548 1558 O
abnormality 77 88 1559 1570 O
that 89 93 1571 1575 O
may 94 97 1576 1579 O
increase 98 106 1580 1588 O
the 107 110 1589 1592 O
risk 111 115 1593 1597 O
associated 116 126 1598 1608 O
with 127 131 1609 1613 O
study 132 137 1614 1619 O
participation 138 151 1620 1633 O
or 152 154 1634 1636 O
investigational 155 170 1637 1652 B-treatment
product 171 178 1653 1660 I-treatment
administration 179 193 1661 1675 O
or 194 196 1676 1678 O
may 197 200 1679 1682 O
interfere 201 210 1683 1692 O
with 211 215 1693 1697 O
the 216 219 1698 1701 O
interpretation 220 234 1702 1716 O
of 235 237 1717 1719 O
study 238 243 1720 1725 O
results 244 251 1726 1733 O
and 252 255 1734 1737 O
, 255 256 1737 1738 O
in 257 259 1739 1741 O
the 260 263 1742 1745 O
judgment 264 272 1746 1754 O
of 273 275 1755 1757 O
the 276 279 1758 1761 O
investigator 280 292 1762 1774 O
, 292 293 1774 1775 O
would 294 299 1776 1781 O
make 300 304 1782 1786 O
the 305 308 1787 1790 O
subject 309 316 1791 1798 O
inappropriate 317 330 1799 1812 O
for 331 334 1813 1816 O
entry 335 340 1817 1822 O
into 341 345 1823 1827 O
this 346 350 1828 1832 O
study 351 356 1833 1838 O

Participation 0 13 1839 1852 O
in 14 16 1853 1855 O
other 17 22 1856 1861 O
studies 23 30 1862 1869 O
involving 31 40 1870 1879 O
investigational 41 56 1880 1895 B-treatment
drug(s 57 63 1896 1902 I-treatment
) 63 64 1902 1903 I-treatment
or 65 67 1904 1906 O
treatment 68 77 1907 1916 B-treatment
with 78 82 1917 1921 I-treatment
an 83 85 1922 1924 I-treatment
investigational 86 101 1925 1940 I-treatment
drug 102 106 1941 1945 I-treatment
within 107 113 1946 1952 O
30 114 116 1953 1955 B-upper_bound
days 117 121 1956 1960 I-upper_bound
or 122 124 1961 1963 O
5 125 126 1964 1965 B-upper_bound
half 127 131 1966 1970 O
lives 132 137 1971 1976 O
prior 138 143 1977 1982 O
to 144 146 1983 1985 O
study 147 152 1986 1991 O
entry 153 158 1992 1997 O
and/or 159 165 1998 2004 O
during 166 172 2005 2011 O
study 173 178 2012 2017 O
participation 179 192 2018 2031 O

Pregnant 0 8 2032 2040 B-pregnancy
females 9 16 2041 2048 B-gender

Serum 0 5 2049 2054 B-clinical_variable
CK 6 8 2055 2057 I-clinical_variable
levels 9 15 2058 2064 I-clinical_variable
> 16 17 2065 2066 O
3x 17 19 2066 2068 B-lower_bound
ULN 20 23 2069 2072 I-lower_bound

Steroid 0 7 2073 2080 B-treatment
inhalers 8 16 2081 2089 I-treatment
and 17 20 2090 2093 O
topical 21 28 2094 2101 B-treatment
steroids 29 37 2102 2110 I-treatment
may 38 41 2111 2114 O
be 42 44 2115 2117 O
used 45 49 2118 2122 O

Subject 0 7 2123 2130 O
with 8 12 2131 2135 O
a 13 14 2136 2137 O
history 15 22 2138 2145 O
of 23 25 2146 2148 O
malignancies 26 38 2149 2161 B-cancer
that 39 43 2162 2166 O
have 44 48 2167 2171 O
been 49 53 2172 2176 O
surgically 54 64 2177 2187 O
removed 65 72 2188 2195 O
or 73 75 2196 2198 O
eradicated 76 86 2199 2209 O
by 87 89 2210 2212 O
irradiation 90 101 2213 2224 B-treatment
or 102 104 2225 2227 O
chemotherapy 105 117 2228 2240 B-treatment
and 118 121 2241 2244 O
who 122 125 2245 2248 O
have 126 130 2249 2253 O
no 131 133 2254 2256 O
evidence 134 142 2257 2265 O
of 143 145 2266 2268 O
recurrence 146 156 2269 2279 O
for 157 160 2280 2283 O
at 161 163 2284 2286 O
least 164 169 2287 2292 O
5 170 171 2293 2294 B-lower_bound
years 172 177 2295 2300 I-lower_bound
before 178 184 2301 2307 I-lower_bound
Screening 185 194 2308 2317 O

Subjects 0 8 2318 2326 O
aged 9 13 2327 2331 B-age
1 14 15 2332 2333 B-lower_bound
to 16 18 2334 2336 O
16 19 21 2337 2339 B-upper_bound
years 22 27 2340 2345 I-upper_bound
who 28 31 2346 2349 O
in 32 34 2350 2352 O
the 35 38 2353 2356 O
judgment 39 47 2357 2365 O
of 48 50 2366 2368 O
the 51 54 2369 2372 O
investigator 55 67 2373 2385 O
are 68 71 2386 2389 O
candidates 72 82 2390 2400 O
for 83 86 2401 2404 O
gastric 87 94 2405 2412 B-treatment
acid 95 99 2413 2417 I-treatment
suppression 100 111 2418 2429 I-treatment
therapy 112 119 2430 2437 I-treatment
( 120 121 2438 2439 O
ie 121 123 2439 2441 O
, 123 124 2441 2442 O
those 125 130 2443 2448 O
with 131 135 2449 2453 O
a 136 137 2454 2455 O
presumptive 138 149 2456 2467 O
diagnosis 150 159 2468 2477 O
of 160 162 2478 2480 O
GERD 163 167 2481 2485 B-chronic_disease
, 167 168 2485 2486 O
a 169 170 2487 2488 O
clinical 171 179 2489 2497 O
diagnosis 180 189 2498 2507 O
of 190 192 2508 2510 O
suspected 193 202 2511 2520 O
GERD 203 207 2521 2525 O
, 207 208 2525 2526 O
symptomatic 209 220 2527 2538 O
GERD 221 225 2539 2543 O
, 225 226 2543 2544 O
or 227 229 2545 2547 O
endoscopically 230 244 2548 2562 O
proven 245 251 2563 2569 O
GERD 252 256 2570 2574 O
) 256 257 2574 2575 O
and 258 261 2576 2579 O
whom 262 266 2580 2584 O
the 267 270 2585 2588 O
investigator 271 283 2589 2601 O
judges 284 290 2602 2608 O
would 291 296 2609 2614 O
need 297 301 2615 2619 O
to 302 304 2620 2622 O
receive 305 312 2623 2630 O
IV 313 315 2631 2633 B-treatment
PPI 316 319 2634 2637 I-treatment
therapy 320 327 2638 2645 I-treatment
for 328 331 2646 2649 O
at 332 334 2650 2652 O
least 335 340 2653 2658 O
4 341 342 2659 2660 B-lower_bound
days 343 347 2661 2665 I-lower_bound

Use 0 3 2666 2669 O
of 4 6 2670 2672 O
H2RAs 7 12 2673 2678 B-treatment
, 12 13 2678 2679 O
sucralfate 14 24 2680 2690 B-treatment
, 24 25 2690 2691 O
misoprostol 26 37 2692 2703 B-treatment
, 37 38 2703 2704 O
or 39 41 2705 2707 O
prokinetic 42 52 2708 2718 B-treatment
agents 53 59 2719 2725 I-treatment
, 59 60 2725 2726 O
and 61 64 2727 2730 O
bismuth 65 72 2731 2738 B-treatment
preparations 73 85 2739 2751 I-treatment
within 86 92 2752 2758 O
1 93 94 2759 2760 B-upper_bound
day 95 98 2761 2764 I-upper_bound
( 99 100 2765 2766 I-upper_bound
24 100 102 2766 2768 I-upper_bound
hours 103 108 2769 2774 I-upper_bound
) 108 109 2774 2775 I-upper_bound
before 110 116 2776 2782 O
investigational 117 132 2783 2798 B-treatment
product 133 140 2799 2806 I-treatment
dosing 141 147 2807 2813 O
on 148 150 2814 2816 O
Day 151 154 2817 2820 O
1 155 156 2821 2822 O

Y 0 1 2823 2824 O
- 1 2 2824 2825 O
site 2 6 2825 2829 O
or 7 9 2830 2832 O
dedicated 10 19 2833 2842 O
IV 20 22 2843 2845 O
line 23 27 2846 2850 O
for 28 31 2851 2854 O
administration 32 46 2855 2869 O
of 47 49 2870 2872 O
pantoprazole 50 62 2873 2885 B-treatment
sodium 63 69 2886 2892 I-treatment

breastfeeding 0 13 2893 2906 O
females 14 21 2907 2914 B-gender

fertile 0 7 2915 2922 O
male 8 12 2923 2927 B-gender
subjects 13 21 2928 2936 I-gender
, 21 22 2936 2937 O
and 23 26 2938 2941 O
female 27 33 2942 2948 B-gender
subjects 34 42 2949 2957 I-gender
of 43 45 2958 2960 O
childbearing 46 58 2961 2973 O
potential 59 68 2974 2983 O
who 69 72 2984 2987 O
are 73 76 2988 2991 O
unwilling 77 86 2992 3001 B-contraception_consent
or 87 89 3002 3004 I-contraception_consent
unable 90 96 3005 3011 I-contraception_consent
to 97 99 3012 3014 I-contraception_consent
use 100 103 3015 3018 I-contraception_consent
a 104 105 3019 3020 I-contraception_consent
highly 106 112 3021 3027 I-contraception_consent
effective 113 122 3028 3037 I-contraception_consent
method 123 129 3038 3044 I-contraception_consent
of 130 132 3045 3047 I-contraception_consent
contraception 133 146 3048 3061 I-contraception_consent
for 147 150 3062 3065 O
the 151 154 3066 3069 O
duration 155 163 3070 3078 O
of 164 166 3079 3081 O
the 167 170 3082 3085 O
study 171 176 3086 3091 O
and 177 180 3092 3095 O
for 181 184 3096 3099 O
at 185 187 3100 3102 O
least 188 193 3103 3108 O
28 194 196 3109 3111 B-lower_bound
days 197 201 3112 3116 I-lower_bound
after 202 207 3117 3122 I-lower_bound
last 208 212 3123 3127 O
dose 213 217 3128 3132 O
of 218 220 3133 3135 O
investigational 221 236 3136 3151 O
product 237 244 3152 3159 O

